-
Company Insights
Innovation and Patenting activity of Harvia Oy Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Harvia Oy Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Sector Analysis
Lithuania Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Lithuania Defense Market Report Overview The Lithuania defense budget was worth $2.1Â billion in 2024 and will grow at a CAGR of more than 6% during 2025-2029. The budget will grow because of modernization commitments by the Lithuanian government and additional threats, including the conflict in Ukraine, have heightened the need for military spending. The Lithuanian military is pursuing several programs, including the acquisition of armored vehicles, M142 HIMARS, and Black Hawk helicopters to provide it with more modern capabilities. Lithuania...
-
Sector Analysis
Finland Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Finland Construction Market Report Overview The Finland construction market size was $46.5 billion in 2023. The market is expected to achieve an AAGR of more than 2% during 2025-2028. The growth of the market is attributed to the government’s efforts to develop transport, housing, and industrial infrastructure. Investments as part of the modified Recovery and Resilience Plan (RRP) approved in November 2023, with a strong focus on green transition, will also aid the forecast period growth in the construction market....
-
Sector Analysis
NewNew Drug Approvals and Their Contract Manufacture – 2024 Edition
This report is the 14th edition of our long-running analysis of the CMO industry, using the FDA's NDA approvals as the primary indicator of performance. New Drug Approvals and Their Contract Manufacture (formerly called "CMO Scorecard") is critical for benchmarking the performance of the contract manufacturing organization (CMO) industry and the relative performance of major CMOs. This year's edition includes a discussion of how inflation and increasing global conflict has impacted pharma manufacturers.
-
Sector Analysis
CAD/CAM Systems and Materials Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
CAD/CAM Systems and Materials Market Report Overview The CAD/CAM systems and materials market size was valued at $3.93 billion in 2023 and is expected to grow at a CAGR of more than 5% during the forecast period 2023 and 2033. CAD/CAM systems are utilized to process and fabricate dental prosthodontics such as crowns, crown lays, veneers, inlays and onlays, fixed bridges, dental implant restorations, and dentures. CAD/CAM systems offer unique advantages when compared to traditional methods such as a reduction...
-
Product Insights
Birch Pollen Allergy – Drugs In Development, 2023
Global Markets Direct’s, ‘Birch Pollen Allergy - Drugs In Development, 2023’, provides an overview of the Birch Pollen Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Birch Pollen Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Limbal Stem Cell Deficiency (LSCD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Limbal Stem Cell Deficiency (LSCD) - Drugs In Development, 2023’, provides an overview of the Limbal Stem Cell Deficiency (LSCD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Limbal Stem Cell Deficiency (LSCD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Pollen Allergy – Drugs In Development, 2023
Global Markets Direct’s, ‘Pollen Allergy - Drugs In Development, 2023’, provides an overview of the Pollen Allergy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pollen Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chemotherapy Induced Neutropenia – Drugs In Development, 2023
Global Markets Direct’s, ‘Chemotherapy Induced Neutropenia - Drugs In Development, 2023’, provides an overview of the Chemotherapy Induced Neutropenia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chemotherapy Induced Neutropenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Anaplastic Thyroid Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Anaplastic Thyroid Cancer - Drugs In Development, 2023’, provides an overview of the Anaplastic Thyroid Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anaplastic Thyroid Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...